NAION is an extremely rare event caused by reduced blood flow to the front portion of the optic nerve which typically causes sudden, painless loss of vision in one eye
Patients filed lawsuits claiming Pfizer failed to alert them to these dangers, and the FDA required the manufacturer to include warnings about the drugs risks
Cagrilintide peptide 5mg is studied in laboratory research for peptide-related experimental applications
Compared to DPP4 inhibitor, GLP-1RA use was associated with decreased risks of 30 outcomes, including respiratory failure, pneumonia, anemia, post-thrombotic sequelae, and bacterial infections, and increased risk of 13 outcomes, including sleep disturbances, nausea, vomiting, headaches, hypotension, sleep disturbances, and nephrolithiasis
One or more of three potential pathways may be involved: these are deposition of the drug per se or a metabolite thereof, stimulation of melanin production, and bacterial metabolism of the drug, alone or in combination [5]
What makes this mask special